Comerica Bank’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$135K Hold
55,000
﹤0.01% 2501
2025
Q3
$369K Hold
55,000
﹤0.01% 2025
2025
Q2
$323K Hold
55,000
﹤0.01% 2102
2025
Q1
$461K Hold
55,000
﹤0.01% 1883
2024
Q4
$409K Hold
55,000
﹤0.01% 1971
2024
Q3
$319K Buy
55,000
+40,000
+267% +$257K ﹤0.01% 2095
2024
Q2
$99.8K Buy
15,000
+14,937
+23,710% +$121K ﹤0.01% 2543
2024
Q1
$816 Buy
+63
New +$840 ﹤0.01% 3639
2023
Q4
Sell
-569
Closed -$7.46K 3831
2023
Q3
$7.46K Buy
+569
New +$10.4K ﹤0.01% 3259

Other funds holding TMCI

Comerica Bank's TMCI Position: Q4 2025 in Review

Comerica Bank held its Treace Medical Concepts (TMCI) position steady in Q4 2025 at 55,000 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Comerica Bank first reported a position in TMCI in Q3 2023 and has held it in 9 quarters since. The position peaked at $461K in Q1 2025. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Comerica Bank held 55,000 shares of Treace Medical Concepts worth $135K as of Q4 2025.
  • Comerica Bank left its Treace Medical Concepts share count unchanged in Q4 2025.
  • Treace Medical Concepts made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2501 holding.
  • Comerica Bank first reported a position in Treace Medical Concepts in Q3 2023 and has held it in 9 quarters since.
  • Comerica Bank's Treace Medical Concepts position peaked at $461K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.